risperac lösung 1 mg/ml
ac pharma aktiengesellschaft (3240354) - risperidon - lösung zum einnehmen - risperidon (24756) 1 milligramm
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - alle anderen therapeutischen produkte - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
risperac ft 6 mg
ac pharma aktiengesellschaft (3240354) - risperidon - filmtablette - risperidon (24756) 6 milligramm
risperac ft 4 mg
ac pharma aktiengesellschaft (3240354) - risperidon - filmtablette - risperidon 4.mg
risperac ft 3 mg
ac pharma aktiengesellschaft (3240354) - risperidon - filmtablette - risperidon (24756) 3 milligramm
risperac ft 1 mg
ac pharma aktiengesellschaft (3240354) - risperidon - filmtablette - risperidon (24756) 1 milligramm
risperac ft 2 mg
ac pharma aktiengesellschaft (3240354) - risperidon - filmtablette - risperidon (24756) 2 milligramm
risperac ft 0,5 mg
ac pharma aktiengesellschaft (3240354) - risperidon - filmtablette - risperidon 0.5mg
risperdoc 6 mg
docpharm arzneimittelvertrieb gmbh & co. kommanditgesellschaft auf aktien (8010222) - risperidon - filmtablette - risperidon (24756) 6 milligramm
carboplatin onkovis 10 mg/ml infusionslösung
onkovis gmbh (8111905) - carboplatin - infusionslösung - teil 1 - infusionslösung; carboplatin (23168) 50 milligramm